Cargando…

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.

Detalles Bibliográficos
Autores principales: Mulder, N. H., de Vries, E. G., Sleijfer, D. T., Schraffordt Koops, H., Willemse, P. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977744/
https://www.ncbi.nlm.nih.gov/pubmed/1739635
_version_ 1782135328018006016
author Mulder, N. H.
de Vries, E. G.
Sleijfer, D. T.
Schraffordt Koops, H.
Willemse, P. H.
author_facet Mulder, N. H.
de Vries, E. G.
Sleijfer, D. T.
Schraffordt Koops, H.
Willemse, P. H.
author_sort Mulder, N. H.
collection PubMed
description
format Text
id pubmed-1977744
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19777442009-09-10 Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma. Mulder, N. H. de Vries, E. G. Sleijfer, D. T. Schraffordt Koops, H. Willemse, P. H. Br J Cancer Research Article Nature Publishing Group 1992-02 /pmc/articles/PMC1977744/ /pubmed/1739635 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Mulder, N. H.
de Vries, E. G.
Sleijfer, D. T.
Schraffordt Koops, H.
Willemse, P. H.
Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
title Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
title_full Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
title_fullStr Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
title_full_unstemmed Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
title_short Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
title_sort dacarbazine (dtic), human recombinant interferon alpha 2a (roferon) and 5-fluorouracil for disseminated malignant melanoma.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977744/
https://www.ncbi.nlm.nih.gov/pubmed/1739635
work_keys_str_mv AT muldernh dacarbazinedtichumanrecombinantinterferonalpha2aroferonand5fluorouracilfordisseminatedmalignantmelanoma
AT devrieseg dacarbazinedtichumanrecombinantinterferonalpha2aroferonand5fluorouracilfordisseminatedmalignantmelanoma
AT sleijferdt dacarbazinedtichumanrecombinantinterferonalpha2aroferonand5fluorouracilfordisseminatedmalignantmelanoma
AT schraffordtkoopsh dacarbazinedtichumanrecombinantinterferonalpha2aroferonand5fluorouracilfordisseminatedmalignantmelanoma
AT willemseph dacarbazinedtichumanrecombinantinterferonalpha2aroferonand5fluorouracilfordisseminatedmalignantmelanoma